hematopoietic system
• increased bronchoalveolar lavage (BAL) cell count after challenge with escalating doses of MCh, 24 hours after exposure to HDM
|
• increased bronchoalveolar lavage (BAL) cell count after challenge with escalating doses of MCh, 24 hours after exposure to HDM
|
immune system
N |
• normal allergen-induced airway hyperresponsiveness (AHR)
• normal immune response to HDM exposure of airways
• normal immune response in OVA-induced pulmonary inflammation
|
• increased bronchoalveolar lavage (BAL) cell count after challenge with escalating doses of MCh, 24 hours after exposure to HDM
|
• increased bronchoalveolar lavage (BAL) cell count after challenge with escalating doses of MCh, 24 hours after exposure to HDM
|
• decreased bronchoalveolar lavage (BAL) Il-13 levels
|
respiratory system
N |
• normal immune response to HDM exposure of airways
• normal allergen-induced airway hyperresponsiveness (AHR)
• normal immune response in OVA-induced pulmonary inflammation
|